#115 Anthropic at $170B: Should Unicorns Be Forced to IPO?
More or Less
00:00
Navigating Investment Narratives and Ozempic Insights
This chapter explores the complexities of investment strategies and their alignment with capital-intensive opportunities, while introducing survey findings about the medication Ozempic. The discussion highlights contrasting views on Ozempic's potential benefits beyond weight loss, encompassing its role in treating chronic conditions. Additionally, it humorously examines societal attitudes toward weight and the impact of children's activities on personal data, all set against the backdrop of evolving social media algorithms.
Transcript
Play full episode
